Last update 07 Mar 2025
DeuterOncology SA

DeuterOncology SA

Startups
|
Holding Company|
2020|
Belgium
|
10-50
|
www.deuteroncology.com

Overview

Tags

Neoplasms
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
c-Met(Hepatocyte growth factor receptor)2

Related

4
Drugs associated with DeuterOncology SA
JNJ-38877618
Target
c-Met
Mechanism
c-Met inhibitors
Active Org.
Johnson & JohnsonJohnson & Johnson [+1]
Originator Org.
Johnson & JohnsonJohnson & Johnson
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
DO-2
Target
c-Met
Mechanism
c-Met inhibitors
Active Org.
DeuterOncology SADeuterOncology SAStartup
Originator Org.
DeuterOncology SADeuterOncology SAStartup
Active Indication
Lung Cancer [+4]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
DO-7
Target-
Mechanism-
Active Org.
DeuterOncology SADeuterOncology SAStartup
Originator Org.
DeuterOncology SADeuterOncology SAStartup
Active Indication
Lung Cancer
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
3
Clinical Trials associated with DeuterOncology SA
CTIS2023-504897-39-00
/ RecruitingPhase 1
- DO2.22.01
NCT05752552
/ RecruitingPhase 1
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET Kinase Inhibitor, DO-2 in Patients with Advanced or Refractory Solid Tumours
CTIS2024-518581-27-00
/ Not yet recruitingPhase 1
A Study to evaluate the effect of a high-fat meal on the Pharmacokinetics of the Selective MET kinase Inhibitor DO-2 in subjects in good health
100 Clinical Results associated with DeuterOncology SA
Login to view more data
0 Patents (Medical) associated with DeuterOncology SA
Login to view more data
100 Deals associated with DeuterOncology SA
Login to view more data
100 Translational Medicine associated with DeuterOncology SA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
Phase 1
Phase 2
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
JNJ-38877618
 ( c-Met )		Neoplasms
More
Phase 2
DO-2
 ( c-Met )		Advanced Malignant Solid Neoplasm
More
Phase 1
DO-7
Lung Cancer
More
Discovery
DO-11
Lung Cancer
More
Discovery
DO-5
 ( Phosphotransferases x c-Met )		Lung Cancer
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free